Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2026-05-17 @ 8:56 PM
Study NCT ID:
NCT04769258
Status:
UNKNOWN
Last Update Posted:
2021-02-24
First Post:
2021-02-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD)
Sponsor:
Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IGIBD001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None